drugset / Trial / NCT01005771
Study to Assess the Efficacy and Safety of GF-001001-00 Cream in Secondarily-Infected Traumatic Lesions
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a double-blind, randomized, placebo-controlled, parallel-group, dose-finding study.
Timeline
- Start
- 2009-09
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ozenoxacin | Other / unclassified | 0.25 % | Topical |
| Subject | Ozenoxacin | Other / unclassified | 1 % | Topical |
| Subject | Ozenoxacin | Other / unclassified | 2 % | Topical |
Indications
No indication recorded.